Welcome
Support Centre
06 January 2009 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A randomised prospective study to evaluate laser peripheral iridotomy with YAG laser against sequential argon-YAG laser in dark irides
ISRCTN ISRCTN82666926
ClinicalTrials.gov identifier
Public title A randomised prospective study to evaluate laser peripheral iridotomy with YAG laser against sequential argon-YAG laser in dark irides
Scientific title
Acronym N/A
Serial number at source N0141184531
Study hypothesis To identify the advantages of combined argon-YAG laser iridotomy versus YAG laser alone, in patients of darkly pigmented irides.
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Eye Diseases: Pigmentation disorders
Participants - inclusion criteria 1. Require iridotomy in both eyes
2. Informed consent available
3. Can follow up after 3 months
4. Dark irides
Participants - exclusion criteria 1. Previous failed laser iridotomy
2. History of previous intraocular pathology affecting iris morphology
3. Patients with only 1 functional eye or previous ACG
4. Patients with advanced glaucoma
5. Patients medically unfit for laser treatment
Anticipated start date 23/08/2006
Anticipated end date 22/01/2007
Status of trial Completed
Patient information material
Target number of participants 30
Interventions Randomised controlled study

1. Pure YAG laser
2. Argon-YAG Laser
Primary outcome measure(s) Total YAG laser power utilised
Secondary outcome measure(s) 1. Complications (iris haemorrhage, elevated intraocular pressure, intraocular inflammation, focal corneal opacity)
2. Patency of laser iridotomy after single treatment
3. Cost implications of 2 laser treatments versus need for failed iridotomy requiring a second treatment
Sources of funding Moorfields Eye Hospital NHS Foundation Trust
NHS R&D Support Funding
Trial website
Publications
Contact name Mr  Julian  DeSilva
  Address Moorfields Eye Hospital
162 City Road

  City/town London
  Zip/Postcode EC1V 2PD
  Country United Kingdom
Sponsor Record Provided by the NHSTCT Register - 2007 Update - Department of Health
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 28/09/2007
Last edited 06/11/2007
Date ISRCTN assigned 28/09/2007
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central